Immune to Cancer: The CRI Blog
-
Tom Marsilje’s Immunotherapy Story
Colorectal Cancer | Diagnosed June 4, 2012 In my 20 years of experience, I have never seen before… -
T.J. Sharpe’s Immunotherapy Story
Melanoma | Diagnosed 2012 When I was in the hospital, I made a vow that when I was… -
Karen Koehler’s Immunotherapy Story
Leukemia | Diagnosed 2011 It was brutal, but I was prepared…I bounced back very quickly. Karen’s Story When… -
Jon Deisher’s Immunotherapy Story
Esophageal Cancer | Diagnosed 2013 Jon’s Story Jon Deisher is a life-long Alaskan who has devoted himself to… -
Ann Silberman’s Immunotherapy Story
Breast Cancer | Diagnosed 2009 You learn to see life in a different way when you know… -
Colorectal Cancer Awareness Month: How Immunotherapy Offers Hope for the Future
March is Colorectal Cancer Awareness Month, and the need for a spotlight on this disease is as…
-
Meet Tecla: 50-Mile Rider in the 2017 Answer to Cancer
For Tecla Palli-Sandler, participating in the 2017 Answer to Cancer Cycling Event and 5K Family…
-
New Biomarker ‘Bim’ Could Enable Smarter Treatment for Melanoma Patients
Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who…
-
Third Immunotherapy Option Approved for Bladder Cancer Patients
On February 2, nivolumab (Opdivo®, Bristol-Myers Squibb) became the newest FDA-approved immunotherapy available for patients with bladder…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.